spacer
home > pmps > spring 2017 > easy access
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Easy Access

Times have changed dramatically in the past 10 years, with external cost pressure, patent losses, dried-up R&D pipelines and the rise of biosimilars forcing Big Pharma to rethink its business models. All of a sudden, the cost of packaging drugs can make a telling difference to the bottom line, or even mean the difference between winning a tender or not.

All of this comes in an environment where patients are hoping for greater protection from external contamination, counterfeits and their children accessing dangerous drugs, and payers are expecting the industry to demonstrate the effectiveness of their products. But how can pharmaceutical companies balance the conflicting needs of lower cost and higher protection?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Reed is Marketing and Strategy Director for Amcor Flexibles Global Pharma and Medical EMEA businesses. He has 19 years of experience in pharmaceutical packaging and has held previous leadership positions in operations and marketing, including managing businesses in the Asia- Pacific region. Colin holds a Bachelor of Engineering degree and an MBA from Aston University, UK.

Greg Rosati is currently the Healthcare Marketing Director for Amcor Rigid Plastics. He has 24 years of packaging experience including 15 in healthcare and has held various leadership roles in product development, sales, marketing and quality systems. Greg holds a BS from Michigan State University, US.
spacer
Colin Reed
spacer
spacer
spacer
Greg Rosati
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

TheVax Genetics Vaccine CO., Ltd and Biotechpharma UAB to collaborate on cGMP production of THEVAX HBV Vaccine

VILNIUS, Lithuania and TAIPEI, Taiwan, April 30, 2018 /PRNewswire/ -- TheVax Genetics Vaccine CO., Ltd (6567.TWO) and Biotechpharma UAB have entered into a manufacturing agreement to produce THEVAX HBV vaccine for first-in-human clinical trials.
More info >>

White Papers

Contemporary Issues in Comparator Trial Supply

Clinigen CTS

As trial design and execution becomes ever-more complex, initiatives to adapt, increase efficiency and control costs without compromising quality become paramount. Here, Clinigen CTS covers the broad issues and summarises the responses our industry is making in this increasingly demanding landscape.
More info >>

 
Industry Events

Outsourcing in Clinical Trials Medical Device USA 2018

11-12 July 2018, Minneapolis, Minnesota

6th Outsourcing in Clinical Trials conference is the only clinical outsourcing platform for medical device companies within Medical Alley this year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement